CRIS Current Research Information System

DOMENICALI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.578
AS - Asia 9.557
EU - Europa 6.578
SA - Sud America 588
Continente sconosciuto - Info sul continente non disponibili 518
AF - Africa 456
OC - Oceania 24
AN - Antartide 1
Totale 28.300
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.376
VN - Vietnam 2.837
SG - Singapore 2.301
CN - Cina 2.142
IT - Italia 1.690
GB - Regno Unito 1.251
HK - Hong Kong 851
SE - Svezia 709
DE - Germania 679
FR - Francia 435
BR - Brasile 405
IN - India 357
RU - Federazione Russa 296
NL - Olanda 248
BD - Bangladesh 245
IE - Irlanda 233
UA - Ucraina 220
CH - Svizzera 195
KR - Corea 154
JP - Giappone 147
ZA - Sudafrica 145
TG - Togo 127
CA - Canada 113
FI - Finlandia 108
BG - Bulgaria 100
EE - Estonia 94
CI - Costa d'Avorio 87
JO - Giordania 77
AT - Austria 72
TH - Thailandia 68
AR - Argentina 67
ES - Italia 63
PH - Filippine 62
ID - Indonesia 45
PL - Polonia 42
IR - Iran 41
EC - Ecuador 38
TR - Turchia 37
BE - Belgio 35
MX - Messico 34
SC - Seychelles 34
CL - Cile 31
IQ - Iraq 29
PK - Pakistan 25
SA - Arabia Saudita 21
AU - Australia 20
GR - Grecia 20
TW - Taiwan 20
CO - Colombia 19
UZ - Uzbekistan 19
HR - Croazia 14
MY - Malesia 14
JM - Giamaica 13
AE - Emirati Arabi Uniti 12
CZ - Repubblica Ceca 12
MA - Marocco 12
RO - Romania 12
LB - Libano 11
LT - Lituania 11
CR - Costa Rica 9
ET - Etiopia 9
IL - Israele 9
NG - Nigeria 9
TN - Tunisia 9
PY - Paraguay 8
VE - Venezuela 8
HN - Honduras 7
TT - Trinidad e Tobago 7
EG - Egitto 6
NP - Nepal 5
PE - Perù 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
AZ - Azerbaigian 4
DK - Danimarca 4
DZ - Algeria 4
LV - Lettonia 4
MU - Mauritius 4
NO - Norvegia 4
XK - ???statistics.table.value.countryCode.XK??? 4
DO - Repubblica Dominicana 3
GH - Ghana 3
GT - Guatemala 3
HU - Ungheria 3
KZ - Kazakistan 3
LU - Lussemburgo 3
MD - Moldavia 3
MN - Mongolia 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
SV - El Salvador 3
UY - Uruguay 3
BO - Bolivia 2
EU - Europa 2
KE - Kenya 2
KG - Kirghizistan 2
KH - Cambogia 2
MM - Myanmar 2
NZ - Nuova Zelanda 2
Totale 27.757
Salva come PNG Salva come JPEG
Città #
Singapore 1.543
Ashburn 1.066
Southend 1.064
Fairfield 874
Hong Kong 794
San Jose 744
Chandler 700
Ho Chi Minh City 580
Santa Clara 533
Hanoi 529
Dong Ket 470
Woodbridge 445
Bologna 382
Seattle 371
Hefei 370
Houston 370
Wilmington 365
Cambridge 322
Council Bluffs 310
Princeton 273
Beijing 257
Boardman 250
Ann Arbor 236
Dublin 230
Los Angeles 201
Bern 178
Milan 156
Lauterbourg 150
Seoul 131
New York 129
Jacksonville 126
Lomé 126
Dallas 125
Tokyo 117
Nanjing 115
Westminster 107
Sofia 99
Padova 97
Da Nang 95
Abidjan 87
Berlin 81
Buffalo 80
Amman 76
Helsinki 75
Haiphong 72
Munich 68
Florence 66
Turin 65
San Diego 64
Rome 63
Shanghai 62
Jinan 60
Saint Petersburg 60
Shenyang 60
Guangzhou 54
São Paulo 52
Redondo Beach 51
Vienna 48
Frankfurt am Main 46
Changsha 44
Chicago 40
Hebei 40
Bengaluru 39
Tianjin 39
Hải Dương 34
Johannesburg 34
London 34
Amsterdam 33
Nuremberg 32
Brussels 31
Phoenix 31
Bangkok 30
Nanchang 30
Redmond 30
Dearborn 29
Mülheim 29
Paris 29
San Francisco 29
Orem 28
Toronto 28
Atlanta 26
Biên Hòa 26
Can Tho 26
Montreal 26
Brooklyn 25
Jakarta 24
Naples 24
Rimini 24
Warsaw 24
Falkenstein 23
Jiaxing 23
Medford 23
Norwalk 23
Zhengzhou 23
Bremen 21
Hangzhou 21
Thái Nguyên 21
Düsseldorf 20
Redwood City 20
Barcelona 19
Totale 17.475
Salva come PNG Salva come JPEG
Nome #
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals 336
Accesses for alcohol intoxication to the emergency department and the risk of re-hospitalization: An observational retrospective study 309
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 294
Ethical and legal implications of health monitoring wearable devices: A scoping review 271
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 271
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 270
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 256
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 253
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 248
A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. 244
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 243
A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection. 234
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma 232
Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status. 229
A novel model of CCl4-induced cirrosi with ascites in the mouse. 228
The nutritional status modulates preservation-reperfusion injury in rat fatty liver. 226
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 226
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 225
Low haemoglobin level predicts early hospital readmission in patients with cirrhosis and acute decompensation 224
A novel sodium overload test predicting ascites decompensation in rats with CCL4-induced cirrhosis. 224
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 219
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 219
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 217
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET) 216
Mortality and its association with chronic alcohol-related diseases in patients admitted to the emergency department for acute alcoholic intoxication: retrospective cohort study 214
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. 214
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 213
The reduced tolerance of rat fatty liver to ischemia-reperfusion is associated to mitochondrial oxidative injury. 212
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 210
Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis. 210
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study 210
Clinical indications for the albumin use: Still a controversial issue. 209
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 209
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 209
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury 202
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 202
Metabolic disorders across hepatocellular carcinoma in Italy 201
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 201
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 199
Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis. 198
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. 197
C-type natriuretic peptide (CNP) favours natriuresis in pre-ascitic cirrhotic patients. 196
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 196
The role of the circadian timing system in sarcopenia in old age: a scoping review 196
Daily profile of circulating c-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects. Relationship with renal function. 194
Transthoracic electrical bioimpedance: a non-invasive technique for the evaluation of the hemodynamic alterations in patients with liver cirrhosis. 194
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. 193
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. 192
Portal vein arterialization for the treatment of post resection acute liver failure in the rat. 192
Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study 192
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. 190
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. 190
Real-world experience with long-term albumin in patients with cirrhosis and ascites 189
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study. 189
The endocannabinoid system and liver diseases. 186
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischemia-reperfusion injury complicated by endotoxemia. 185
Successful treatment of CCl4-induced acute liver failure with portal vein arterialization in the rat. 185
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People 184
QT Interval Correction in Patients with Cirrhosis 183
Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. 181
Development and validation of a scoring system that includes corrected QT interval for risk analysis of patients with cirrhosis and gastrointestinal bleeding 181
Effect of the cannabinoid CB1 receptor antagonist SR141716 in a rat model of liver inflammation 180
Acute-on-chronic liver failure is a distinct syndrome developing in patients with acute dcompensation of cirrhosis. 180
Predictors of clinical trajectories of patients with acutely decompensated cirrhosis. An external validation of the PREDICT study 179
QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis. 177
How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. 175
Dorsal acoustic windows may ameliorate liver ultrasound in patients with liver disease and meteorism/obesity/ascites. 175
Doxorubicin coupled to lactosaminated albumin: effects on rats with liver fibrosis and cirrhosis. 173
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study 172
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 172
Wearable sensors for monitoring caregivers of people with dementia: a scoping review 171
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications 171
Portal vein arterialization increases liver regeneration in acute liver failure induced by extended hepatectomy or toxin administration in the rat 171
Gioco responsabile e comportamenti di salute: un progetto di ricerca e intervento in Emilia-Romagna 171
Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study 171
Simple and rapid LC-MS method for the determination of circulating albumin microheterogeneity in veal calves exposed to heat stress 170
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 169
Long-term beta-blockade shortens QT interval prolongation in patients with liver cirrhosis 169
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. 167
Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis. 165
Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis 165
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis 164
Increased anandamide-induced relaxation in mesenteric arteries of cirrhotic rats. Role of cannabinoid and vanilloid receptors. 164
null 164
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. 164
Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation 163
Predictors of clinical trajectories in patients admitted for acutely decompensated cirrhosis: An external validation of the PREDICT study 160
Predictors of clinical courses in patients wih acutely decompensated cirrhosis. An external validation of the PREDICT study 157
A brief up-date of the use of sodium exybate for the treatment of alcohol use disorders. 157
Years of life that could be saved from prevention of hepatocellular carcinoma. 156
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study. 156
QT interval in patients with cirrhosis: failure of Bazett’s correction and identification of a disease-specific formula. 156
The renin-angiotensin-aldosterone system in cirrhosis. 155
L’apparato cardiovascolare dell’anziano. 154
Successful treatment of CCL4-induced acute liver failure with portal vein arterialization in the rat. 154
Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population. 153
Hyposplenism as a cause of pneumococcal meningoencephalitis in an adult patient with coeliac disease 152
Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF) 150
Prevalence of and risk factors for fatty liver in the general population of Northern Italy: The Bagnacavallo Study 150
Caring in the XXI century: the sustainability of long-term care in aging societies—mapping challenges and developing solutions within the Age-It Research Program 149
Totale 19.633
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.573
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.573
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.443 0 94 140 219 204 136 100 174 114 192 676 394
2022/20233.085 280 455 163 365 192 228 89 182 528 70 243 290
2023/20241.050 69 153 91 95 74 200 55 87 46 66 77 37
2024/20253.946 127 567 333 305 689 196 175 85 88 305 187 889
2025/202610.369 739 783 833 718 936 497 1.422 392 1.970 900 536 643
2026/2027753 379 374 0 0 0 0 0 0 0 0 0 0
Totale 28.300